openPR Logo
Press release

North America is Dominated "Intra-Uterine Contraceptive Devices Market" by 2017-2024

Global Intra-Uterine Contraceptive Devices Market Trends, 2017-2024

Global Intra-Uterine Contraceptive Devices Market Trends, 2017-2024

The new published report on “Global Intra-Uterine Contraceptive Devices Market” is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.

Intra-Uterine Contraceptive Devices Market Categories: Segmentation

Global Intra-Uterine Contraceptive Devices Market, By Product Type (Hormonal IUCD, Copper IUCD), End-User (Hospitals, Gynaecology Clinics, Community Healthcare), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)

For a Free Sample Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

TABLE OF CONTENTS

1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. INCREASED RATE OF UNPLANNED PREGNANCIES
3.1.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
3.1.3. FAVOURABLE INSURANCE FOR IUCD’S
3.1.4. GROWING AWARENESS OF CONTRACEPTIVE
3.1.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS
3.1.6. TECHNOLOGICAL ADVANCEMENTS
3.2. RESTRAINTS
3.2.1. HIGH COST OF TREATMENT
3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)
3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY
3.2.4. CHANGES IN GOVERNMENT REGULATIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
7. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.2. NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.2.1. U.S. INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.2.2. CANADA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.2.3. MEXICO INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3. EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.1. GERMANY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.2. FRANCE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.3. ITALY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.4. U.K. INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.5. SWITZERLAND INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.6. NETHERLANDS INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.7. SPAIN INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.8. RUSSIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.9. BELGIUM INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.3.10. TURKEY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4. APAC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.1. CHINA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.2. SOUTH KOREA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.3. JAPAN INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.4. INDIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.5. THAILAND INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.6. SINGAPORE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.7. MALAYSIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.8. PHILIPPINES INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.9. AUSTRALIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.4.10. INDONESIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5. SOUTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.1. BRAZIL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.2. COLOMBIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.3. ARGENTINA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.4. CHILE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.5. ECUADOR INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.6. URUGUAY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.7. PARAGUAY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES
7.5.8. PERU INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.5.9. BOLIVIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.6. MEA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.6.1. EGYPT INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
7.6.2. SAUDI ARABIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
8. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY SHARE
8.1. COMPANY SHARE ANALYSIS: GLOBAL
8.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
8.3. COMPANY SHARE ANALYSIS: EUROPE
8.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
8.5. COMPANY SHARE ANALYSIS: SOUTH AMERICA
8.6. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
9. COMPANY PROFILES
9.1. BAYER AG
9.1.1. COMPANY OVERVIEW
9.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
9.1.3. REVENUE ANALYSIS
9.1.4. PRODUCT PORTFOLIO
9.1.5. RECENT DEVELOPMENTS
9.1.6. DATA BRIDGE ANALYSIS
9.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
9.2.1. COMPANY OVERVIEW
9.2.2. REVENUE ANALYSIS
9.2.3. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
9.2.4. PRODUCT PORTFOLIO
9.2.5. RECENT DEVELOPMENTS
9.2.6. DATA BRIDGE ANALYSIS
9.3. ALLERGEN PLC
9.3.1. COMPANY OVERVIEW
9.3.2. REVENUE ANALYSIS
9.3.3. PRODUCT PORTFOLIO
9.3.4. RECENT DEVELOPMENTS
9.3.5. DATA BRIDGE ANALYSIS
9.4. DKT INTERNATIONAL
9.4.1. COMPANY OVERVIEW
9.4.2. REVENUE ANALYSIS
9.4.3. PRODUCT PORTFOLIO
9.5. SMB CORPORATION
9.5.1. COMPANY OVERVIEW
9.5.2. REVENUE ANALYSIS
9.5.3. PRODUCT PORTFOLIO
9.5.4. RECENT DEVELOPMENTS
9.5.5. DATA BRIDGE ANALYSIS
9.6. OCON MEDICAL LTD.
9.6.1. COMPANY OVERVIEW
9.6.2. REVENUE ANALYSIS
9.6.3. PRODUCT PORTFOLIO
9.6.4. RECENT DEVELOPMENTS
9.6.5. DATA BRIDGE ANALYSIS
9.7. MONA LISA N.V.
9.7.1. COMPANY OVERVIEW
9.7.2. REVENUE ANALYSIS
9.7.3. PRODUCT PORTFOLIO
9.7.4. RECENT DEVELOPMENTS
9.8. MEDISAFE DISTRIBUTION INC.
9.8.1. COMPANY OVERVIEW
9.8.2. REVENUE ANALYSIS
9.8.3. PRODUCT PORTFOLIO
9.8.4. RECENT DEVELOPMENTS
10. RELATED REPORTS

Global Intra-Uterine Contraceptive Devices Market: Market Drivers

Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

Increased Rate of Unplanned Pregnancies:

Adolescents most commonly use contraceptive methods with relatively high typical use failure rates such as condoms, withdrawal, or oral contraceptive (OC) pills. Non-use, inconsistent use, and use of methods with high typical use failure rates are reflected in the high rate of unintended adolescent pregnancies in the U.S.

Rising Number of Initiatives Undertaken By the Private Firms:

The increasing number of initiatives taken by the U.S. government has helped to limit the rising number of unplanned pregnancies and abortions rate in the U.S. In addition, many U.S.-based private firms also contribute towards the solutions for pregnancy-related issues, which include maternal mortality, teenage pregnancies, growing number of abortions, and so on, by promoting the use of contraceptives, such as intrauterine contraceptive devices.

Favourable Insurance for IUCD’s:

The insurance policy is propelling the IUCD market towards growth. In Finland, national insurance covers acute but not preventive care, and contraceptives are usually paid by the patient. In Sweden, the copper IUCDs are available free of cost, whereas hormonal IUCDs are not. All FDA-approved contraceptives in the U.S. are covered by insurance.

Growing Awareness of Contraceptive:

The need to avoid unwanted pregnancies, especially among teenagers, is one of the major drivers for this market. It has also been observed that for over half of the users also identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain and acne, as reasons for use. This is also one of the factors contributing to the growth of the market in Europe.

Speak to Analyst Visit @databridgemarketresearch.com/speak-to-analyst/?dbmr=globa...

Some of the major players operating in this market are:

• Bayer AG
• Teva Pharmaceuticals Industries Ltd.
• Mona Lisa N.V.
• DKT International
• Egemen International
• Melbea AG, Ocon Medical Ltd.
• Pregna International Limited
• Medical Engineering Corporation SA
• SMB Corporation and Meril Life Sciences Pvt. Ltd.
• Medu Scientific Ltd
• China RH Contraceptives Co., Ltd
• Sanghai Jolly Medical Education Co., Ltd
• Bernstein Leibhard LLP
• ZheijangDaji Medical Instruments, Ltd.
• Nimble International
• AME Line
• Technico
• Cepeo
• Contraceptivos
• InjeflexInd
• Com Ltd
• Bersil

The Global Intra-Uterine Contraceptive Devices Market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Bayer AG dominated the IUCD devices market accounting for a highest market share in 2016, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed among others holds 34.0% of the IUCDdelivery market in 2016.

BAYER HEALTHCARE AG

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science. The HealthCare segment offers a wide range of products under animal health, pharmaceuticals, consumer care, and medical care. The pharmaceutical business offers a wide range of products in the therapeutic area of oncology, haematology, and ophthalmology, and offers products for women’s health and cardiology therapeutic applications.

Recent Developments:

In October 2016, Bayer AG has successfully concluded the European registration procedure to gain EUwide marketing authorization for its new low-dose levonorgestrel-releasing intrauterine system (LNGIUS). The product is named Kyleena and will be available in the market from 2017 January.

In September 2016, Bayer AG has successfully received FDA approval for its new low-dose levonorgestrel releasing intrauterine system (LNG-IUS) “Kyleena” The launch of this product in October in U.S.

Read more about the Global Intra-Uterine Contraceptive Devices Market visit @ databridgemarketresearch.com/reports/global-intra-uterine...

Related Report

Global Prosthetic Heart Valve Market – Trends and Forecast to 2024

Global Prosthetic Heart Valve Market, By Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)– Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-prosthetic-he...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America is Dominated "Intra-Uterine Contraceptive Devices Market" by 2017-2024 here

News-ID: 793436 • Views: 136

More Releases from Data Bridge Market Research

Hyper Scale Data Centres Market Evolving Opportunities with Top Industry Players …
Hyperscale Data Center Market Global Analysis 2019 With Leading by Players like: Apple, Intel Corporation, Cisco, Hewlett Packard Enterprise, Cavium Inc, Ericsson, Amazon Web Services, Equinix, Nlyte Software. Key data and information used while preparing this Hyperscale Data Center report has been collected from the consistent sources that range from journals, websites, research papers, case studies, and magazines. Competitor strategies such as new product launches, expansions, agreements, joint ventures, partnerships,
Medical Packaging Films Market Estimated $8.46 Billion Growth by 2026 Report By …
Medical Packaging Films market research report will help companies achieve better decision-making, revenue generation, market goals and profitable businesses in the long term. It also combines all-inclusive industry analysis with specific estimates and forecasts to provide comprehensive research solutions with the greatest possible clarity for strategic decision-making. Therefore, the movements or actions of major market players and brands are analyzed in the medical packaging report, which ranges from product development,
Swab Market :- Key Players are Elmex Controls Pvt Ltd., Copan Diagnostics, Inc., …
According to Data Bridge Market Research new Market report, “Global Swab Market By Test Tpe(DNA, Urine, Saliva),“By Product Type (Alcohol Swab, Cotton Swab, Dry Swab, Gauze Swab), By Shaft(Aluminum, Polypropylene Shaft), By Application(Microbiological Laboratory, Hospitals, Clinics, Academia & Research Institutes), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 1,169 million by 2025, at a
Laser Therapy Market to Shows a High Growth at a CAGR of 12.2% till 2026 | Key C …
The Laser Therapy report offers a thorough examination of the diverse pattern and factors affecting the development direction of the worldwide market. An assessment of the impact of government rules and methodologies accessible assignments is in like manner included giving a widely inclusive layout of the Laser Therapy markets future perspective. the Laser Therapy report fuses into significance information identifying with the regular components of the market and shows refined

All 31363 Releases


More Releases for IUCD

Intrauterine Contraceptive Device Market Report 2018: Segmentation by Type (Horm …
Global Intrauterine Contraceptive Device market research report provides company profile for Medicines360, Pace Pharmaceuticals, Bayer HealthCare, Medisafe Distribution, Teva Pharmaceutical Industrie and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
China IUCD Market Size Estimation by Top Manufacturer, Latest Trends and Industr …
China IUCD Market was about is expected to reach US$ 250 billion by 2023 at a CAGR of 12.7% during forecast period 2017 to 2023. Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1306 IUCD stands for Intra-Uterine Contraceptive Devices. It is a device inserted into the uterus to prevent pregnancy. The device is T-shaped made up of flexible plastic with a coating of thin copper wire. China, ICUD was the most important tool to limit
China IUCD Market Research Report 2017 Analysis and Forecast to 2023
This report provides in depth study of “China IUCD Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The China IUCD Market research report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization. Market
Global IUCD Market 2017 Key Vendors - Egemen International, DKT International, M …
Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Access Full Report @ https://goo.gl/RFXqAR The Global Intra-Uterine Contraceptive Devices Market is highly concentrated to
IUCD Market Future Trends upto 2024 Examined in new market Research Report
In this region, global intra-uterine contraceptive devices market is projected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. Based on geography, the global intra-uterine contraceptive devices (IUCD) market is segmented into 5 geographical regions, such as, North America, South America, Europe, APAC, MEA, Rest Of the World Global intra-uterine contraceptive devices (IUCD) market competition
New Opportunities Explored and Analysis of China IUCD Market
Market Scenario An IUD is a small device that fits inside your womb. It is also known as 'the coil'. It is a T-shaped plastic device that is wrapped in copper or contains hormones. The IUCD works by changing the uterine lining and preventing the fertilized egg from getting attached to the wall of the womb, therefore preventing implantation. There are different types of IUCDs – newer IUCDs contain more copper